1. Home
  2. ICUI vs AMBA Comparison

ICUI vs AMBA Comparison

Compare ICUI & AMBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • AMBA
  • Stock Information
  • Founded
  • ICUI 1984
  • AMBA 2004
  • Country
  • ICUI United States
  • AMBA United States
  • Employees
  • ICUI N/A
  • AMBA N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • AMBA Semiconductors
  • Sector
  • ICUI Health Care
  • AMBA Technology
  • Exchange
  • ICUI Nasdaq
  • AMBA Nasdaq
  • Market Cap
  • ICUI 3.4B
  • AMBA 3.3B
  • IPO Year
  • ICUI 1992
  • AMBA N/A
  • Fundamental
  • Price
  • ICUI $127.40
  • AMBA $63.74
  • Analyst Decision
  • ICUI Strong Buy
  • AMBA Buy
  • Analyst Count
  • ICUI 5
  • AMBA 11
  • Target Price
  • ICUI $196.75
  • AMBA $82.27
  • AVG Volume (30 Days)
  • ICUI 186.2K
  • AMBA 567.0K
  • Earning Date
  • ICUI 08-07-2025
  • AMBA 08-26-2025
  • Dividend Yield
  • ICUI N/A
  • AMBA N/A
  • EPS Growth
  • ICUI N/A
  • AMBA N/A
  • EPS
  • ICUI N/A
  • AMBA N/A
  • Revenue
  • ICUI $2,420,093,000.00
  • AMBA $316,264,000.00
  • Revenue This Year
  • ICUI N/A
  • AMBA $25.21
  • Revenue Next Year
  • ICUI N/A
  • AMBA $10.04
  • P/E Ratio
  • ICUI N/A
  • AMBA N/A
  • Revenue Growth
  • ICUI 7.22
  • AMBA 44.54
  • 52 Week Low
  • ICUI $117.92
  • AMBA $38.86
  • 52 Week High
  • ICUI $196.26
  • AMBA $85.15
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 46.81
  • AMBA 44.55
  • Support Level
  • ICUI $124.39
  • AMBA $66.60
  • Resistance Level
  • ICUI $134.04
  • AMBA $71.94
  • Average True Range (ATR)
  • ICUI 3.75
  • AMBA 2.52
  • MACD
  • ICUI 0.18
  • AMBA -0.82
  • Stochastic Oscillator
  • ICUI 47.55
  • AMBA 20.16

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

Share on Social Networks: